Login / Signup
Yingnan Si
ORCID
Publication Activity (10 Years)
Years Active: 2024-2024
Publications (10 Years): 2
Top Topics
Drug Delivery
Inflammatory Response
Rna Seq
Vascular Endothelial Growth Factor
Top Venues
Cancer research
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Kai Chen
,
Patrick Ernst
,
Anusua Sarkar
,
Seulhee Kim
,
Yingnan Si
,
Tanvi Varadkar
,
Matthew D Ringel
,
Xiaoguang Margaret Liu
,
Lufang Zhou
mLumiOpto is a Mitochondrial-Targeted Gene Therapy for Treating Cancer.
Cancer research
(2024)
Zhuoxin Zhou
,
Yingnan Si
,
Jiashuai Zhang
,
Kai Chen
,
Ashley George
,
Seulhee Kim
,
Lufang Zhou
,
Xiaoguang Margaret Liu
A Dual-Payload Antibody-Drug Conjugate Targeting CD276/B7-H3 Elicits Cytotoxicity and Immune Activation in Triple-Negative Breast Cancer.
Cancer research
(2024)